Literature DB >> 33496222

Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India.

Sriram Selvaraju, Muthusamy Santhosh Kumar, Jeromie Wesley Vivian Thangaraj, Tarun Bhatnagar, Velusamy Saravanakumar, Chethrapilly Purushothaman Girish Kumar, Krithikaa Sekar, Ezhilarasan Ilayaperumal, Ramasamy Sabarinathan, Murugesan Jagadeesan, Masanam Sriramulu Hemalatha, Manoj Vasant Murhekar.   

Abstract

We conducted a cross-sectional survey to estimate the seroprevalence of IgG against severe acute respiratory syndrome coronavirus 2 in Chennai, India. Among 12,405 serum samples tested, weighted seroprevalence was 18.4% (95% CI 14.8%-22.6%). These findings indicate most of the population of Chennai is still susceptible to this virus.

Entities:  

Keywords:  COVID-19; Chennai; IgG; India; SARS; SARS-CoV-2; coronavirus; coronavirus disease; respiratory infections; serosurvey; severe acute respiratory syndrome coronavirus 2; transmission; viruses; zoonoses

Mesh：

Substances：

Year:  2021        PMID： 33496222      PMCID： PMC7853587          DOI： 10.3201/eid2702.203938

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  8 in total

1.  Antibody responses to SARS-CoV-2 in patients with COVID-19.

Authors:  Quan-Xin Long; Bai-Zhong Liu; Hai-Jun Deng; Gui-Cheng Wu; Kun Deng; Yao-Kai Chen; Pu Liao; Jing-Fu Qiu; Yong Lin; Xue-Fei Cai; De-Qiang Wang; Yuan Hu; Ji-Hua Ren; Ni Tang; Yin-Yin Xu; Li-Hua Yu; Zhan Mo; Fang Gong; Xiao-Li Zhang; Wen-Guang Tian; Li Hu; Xian-Xiang Zhang; Jiang-Lin Xiang; Hong-Xin Du; Hua-Wen Liu; Chun-Hui Lang; Xiao-He Luo; Shao-Bo Wu; Xiao-Ping Cui; Zheng Zhou; Man-Man Zhu; Jing Wang; Cheng-Jun Xue; Xiao-Feng Li; Li Wang; Zhi-Jie Li; Kun Wang; Chang-Chun Niu; Qing-Jun Yang; Xiao-Jun Tang; Yong Zhang; Xia-Mao Liu; Jin-Jing Li; De-Chun Zhang; Fan Zhang; Ping Liu; Jun Yuan; Qin Li; Jie-Li Hu; Juan Chen; Ai-Long Huang
Journal:  Nat Med       Date:  2020-04-29       Impact factor: 53.440

2.  Assessing the extent of SARS-CoV-2 circulation through serological studies.

Authors:  Marion Koopmans; Bart Haagmans
Journal:  Nat Med       Date:  2020-08       Impact factor: 53.440

3.  Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.

Authors:  Marina Pollán; Beatriz Pérez-Gómez; Roberto Pastor-Barriuso; Jesús Oteo; Miguel A Hernán; Mayte Pérez-Olmeda; Jose L Sanmartín; Aurora Fernández-García; Israel Cruz; Nerea Fernández de Larrea; Marta Molina; Francisco Rodríguez-Cabrera; Mariano Martín; Paloma Merino-Amador; Jose León Paniagua; Juan F Muñoz-Montalvo; Faustino Blanco; Raquel Yotti
Journal:  Lancet       Date:  2020-07-06       Impact factor: 79.321

4.  Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.

Authors:  Takuya Sekine; André Perez-Potti; Olga Rivera-Ballesteros; Kristoffer Strålin; Jean-Baptiste Gorin; Annika Olsson; Sian Llewellyn-Lacey; Habiba Kamal; Gordana Bogdanovic; Sandra Muschiol; David J Wullimann; Tobias Kammann; Johanna Emgård; Tiphaine Parrot; Elin Folkesson; Olav Rooyackers; Lars I Eriksson; Jan-Inge Henter; Anders Sönnerborg; Tobias Allander; Jan Albert; Morten Nielsen; Jonas Klingström; Sara Gredmark-Russ; Niklas K Björkström; Johan K Sandberg; David A Price; Hans-Gustaf Ljunggren; Soo Aleman; Marcus Buggert
Journal:  Cell       Date:  2020-08-14       Impact factor: 41.582

5.  Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 - April 30, 2020.

Authors: 
Journal:  Indian J Med Res       Date:  2020-05       Impact factor: 2.375

6.  Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.

Authors:  Tyler J Ripperger; Jennifer L Uhrlaub; Makiko Watanabe; Rachel Wong; Yvonne Castaneda; Hannah A Pizzato; Mallory R Thompson; Christine Bradshaw; Craig C Weinkauf; Christian Bime; Heidi L Erickson; Kenneth Knox; Billie Bixby; Sairam Parthasarathy; Sachin Chaudhary; Bhupinder Natt; Elaine Cristan; Tammer El Aini; Franz Rischard; Janet Campion; Madhav Chopra; Michael Insel; Afshin Sam; James L Knepler; Andrew P Capaldi; Catherine M Spier; Michael D Dake; Taylor Edwards; Matthew E Kaplan; Serena Jain Scott; Cameron Hypes; Jarrod Mosier; David T Harris; Bonnie J LaFleur; Ryan Sprissler; Janko Nikolich-Žugich; Deepta Bhattacharya
Journal:  Immunity       Date:  2020-10-14       Impact factor: 31.745

7.  Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.

Authors:  Manoj V Murhekar; Tarun Bhatnagar; Sriram Selvaraju; Kiran Rade; V Saravanakumar; Jeromie Wesley Vivian Thangaraj; Muthusamy Santhosh Kumar; Naman Shah; R Sabarinathan; Alka Turuk; Parveen Kumar Anand; Smita Asthana; Rakesh Balachandar; Sampada Dipak Bangar; Avi Kumar Bansal; Jyothi Bhat; Debjit Chakraborty; Chethana Rangaraju; Vishal Chopra; Dasarathi Das; Alok Kumar Deb; Kangjam Rekha Devi; Gaurav Raj Dwivedi; S Muhammad Salim Khan; Inaamul Haq; M Sunil Kumar; Avula Laxmaiah; Amarendra Mahapatra; Anindya Mitra; A R Nirmala; Avinash Pagdhune; Mariya Amin Qurieshi; Tekumalla Ramarao; Seema Sahay; Y K Sharma; Marinaik Basavegowdanadoddi Shrinivasa; Vijay Kumar Shukla; Prashant Kumar Singh; Ankit Viramgami; Vimith Cheruvathoor Wilson; Rajiv Yadav; C P Girish Kumar; Hanna Elizabeth Luke; Uma Devi Ranganathan; Subash Babu; Krithikaa Sekar; Pragya D Yadav; Gajanan N Sapkal; Aparup Das; Pradeep Das; Shanta Dutta; Rajkumar Hemalatha; Ashwani Kumar; Kanwar Narain; Somashekar Narasimhaiah; Samiran Panda; Sanghamitra Pati; Shripad Patil; Kamalesh Sarkar; Shalini Singh; Rajni Kant; Srikanth Tripathy; G S Toteja; Giridhara R Babu; Shashi Kant; J P Muliyil; Ravindra Mohan Pandey; Swarup Sarkar; Sujeet K Singh; Sanjay Zodpey; Raman R Gangakhedkar; D C S Reddy; Balram Bhargava
Journal:  Indian J Med Res       Date:  2020 Jul & Aug       Impact factor: 2.375

8.  Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020.

Authors:  Zacharoula Bogogiannidou; Alexandros Vontas; Katerina Dadouli; Maria A Kyritsi; Soteris Soteriades; Dimitrios J Nikoulis; Varvara Α Mouchtouri; Michalis Koureas; Evangelos I Kazakos; Emmanouil G Spanos; Georgia Gioula; Evangelia E Ntzani; Alexandros A Eleftheriou; Alkiviadis Vatopoulos; Efthimia Petinaki; Vassiliki Papaevangelou; Matthaios Speletas; Sotirios Tsiodras; Christos Hadjichristodoulou
Journal:  Euro Surveill       Date:  2020-08
  8 in total
  9 in total

1.  SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021.

Authors:  Avula Laxmaiah; Nalam Madhusudhan Rao; N Arlappa; Jagjeevan Babu; P Uday Kumar; Priya Singh; Deepak Sharma; V Mahesh Anumalla; T Santhosh Kumar; R Sabarinathan; M Santhos Kumar; R Ananthan; D Anwar Basha; P P S Blessy; D Chandra Kumar; P Devaraj; S Devendra; M Mahesh Kumar; Indrapal I Meshram; B Naveen Kumar; Paras Sharma; P Raghavendra; P Raghu; K Rajender Rao; P Ravindranadh; B Santosh Kumar; G Sarika; J Srinivasa Rao; M V Surekha; F Sylvia; Deepak Kumar; G Subba Rao; Karthik Bharadwaj Tallapaka; Divya Tej Sowpati; Surabhi Srivastava; V Manoj Murhekar; Rajkumar Hemalatha; Rakesh K Mishra
Journal:  IJID Reg       Date:  2021-11-19

2.  Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications.

Authors:  Andrew T Levin; Nana Owusu-Boaitey; Sierra Pugh; Bailey K Fosdick; Anthony B Zwi; Anup Malani; Satej Soman; Lonni Besançon; Ilya Kashnitsky; Sachin Ganesh; Aloysius McLaughlin; Gayeong Song; Rine Uhm; Daniel Herrera-Esposito; Gustavo de Los Campos; Ana Carolina Pecanha Peçanha Antonio; Enyew Birru Tadese; Gideon Meyerowitz-Katz
Journal:  BMJ Glob Health       Date:  2022-05

3.  Incorporating false negative tests in epidemiological models for SARS-CoV-2 transmission and reconciling with seroprevalence estimates.

Authors:  Rupam Bhattacharyya; Ritoban Kundu; Ritwik Bhaduri; Debashree Ray; Lauren J Beesley; Maxwell Salvatore; Bhramar Mukherjee
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

Review 4.  Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis.

Authors:  Nuzrath Jahan; Adarsha Brahma; Muthusamy Santhosh Kumar; Bhavani Shankara Bagepally; Manickam Ponnaiah; Tarun Bhatnagar; Manoj V Murhekar
Journal:  Int J Infect Dis       Date:  2021-12-28       Impact factor: 12.074

5.  Age- & sex-specific infection fatality ratios for COVID-19 estimated from two serially conducted community-based serosurveys, Chennai, India, 2020.

Authors:  Jeromie Wesley Vivian Thangaraj; Muthusamy Santhosh Kumar; Saravanakumar Velusamy; C P Girish Kumar; Sriram Selvaraju; R Sabarinathan; M Jagadeesan; M S Hemalatha; Tarun Bhatnagar; Manoj Vasant Murhekar
Journal:  Indian J Med Res       Date:  2021-05       Impact factor: 2.375

6.  A seroprevalence study of Covid 19 antibody after 1st wave of the pandemic in South Andaman district, India.

Authors:  Deepak Kumar; Amrita Burma; Ashish Kumar Mandal
Journal:  Clin Epidemiol Glob Health       Date:  2021-11-17

7.  A Comparative Analysis of COVID-19 IgG Antibody Level and Socio-Demographic Status in Symptomatic and Asymptomatic Population of South Andaman, India.

Authors:  Deepak Kumar; Amrita Burma; Ashish Kumar Mandal; Vidhu Joshy
Journal:  Cureus       Date:  2022-02-20

8.  High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey.

Authors:  Antoine N Nkuba; Sheila M Makiala; Emilande Guichet; Paul M Tshiminyi; Yannick M Bazitama; Marc K Yambayamba; Benito M Kazenza; Trésor M Kabeya; Elysee B Matungulu; Lionel K Baketana; Naomi M Mitongo; Guillaume Thaurignac; Fabian H Leendertz; Veerle Vanlerberghe; Raphaël Pelloquin; Jean-François Etard; David Maman; Placide K Mbala; Ahidjo Ayouba; Martine Peeters; Jean-Jacques T Muyembe; Eric Delaporte; Steve M Ahuka
Journal:  Clin Infect Dis       Date:  2022-03-09       Impact factor: 9.079

9.  Seroprevalence of SARS-CoV-2 specific IgG antibodies among eye care workers in South India.

Authors:  Rajapandian Siva Ganesa Karthikeyan; Gunasekaran Rameshkumar; Chidambaranathan Gowri Priya; Prajna Lalitha; Ramamoorthi Devi; Mani Iswarya; Ravilla D Ravindran
Journal:  Indian J Med Microbiol       Date:  2021-07-10       Impact factor: 0.985
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.